BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26150590)

  • 1. M-Trap: Exosome-Based Capture of Tumor Cells as a New Technology in Peritoneal Metastasis.
    de la Fuente A; Alonso-Alconada L; Costa C; Cueva J; Garcia-Caballero T; Lopez-Lopez R; Abal M
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26150590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomimetic device and foreign body reaction cooperate for efficient tumour cell capture in murine advanced ovarian cancer.
    Alonso-Alconada L; de la Fuente A; Santacana M; Ferreiros A; Lopez-Lopez R; Matias-Guiu X; Abal M
    Dis Model Mech; 2020 Jun; 13(6):. PubMed ID: 32764154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer.
    Pascual-Antón L; Cardeñes B; Sainz de la Cuesta R; González-Cortijo L; López-Cabrera M; Cabañas C; Sandoval P
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-environment biomimetics delay peritoneal metastasis formation by deceiving and redirecting disseminated cancer cells.
    De Vlieghere E; Gremonprez F; Verset L; Mariën L; Jones CJ; De Craene B; Berx G; Descamps B; Vanhove C; Remon JP; Ceelen W; Demetter P; Bracke M; De Geest BG; De Wever O
    Biomaterials; 2015 Jun; 54():148-57. PubMed ID: 25907048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome-derived miRNAs and ovarian carcinoma progression.
    Vaksman O; Tropé C; Davidson B; Reich R
    Carcinogenesis; 2014 Sep; 35(9):2113-20. PubMed ID: 24925027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric cancer-derived exosomes promote peritoneal metastasis by destroying the mesothelial barrier.
    Deng G; Qu J; Zhang Y; Che X; Cheng Y; Fan Y; Zhang S; Na D; Liu Y; Qu X
    FEBS Lett; 2017 Jul; 591(14):2167-2179. PubMed ID: 28643334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant ascites in ovarian cancer and the role of targeted therapeutics.
    Smolle E; Taucher V; Haybaeck J
    Anticancer Res; 2014 Apr; 34(4):1553-61. PubMed ID: 24692682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian cancer-derived exosomes promote tumour metastasis
    Alharbi M; Lai A; Guanzon D; Palma C; Zuñiga F; Perrin L; He Y; Hooper JD; Salomon C
    Clin Sci (Lond); 2019 Jul; 133(13):1401-1419. PubMed ID: 31227603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis.
    Sandoval P; Jiménez-Heffernan JA; Rynne-Vidal Á; Pérez-Lozano ML; Gilsanz Á; Ruiz-Carpio V; Reyes R; García-Bordas J; Stamatakis K; Dotor J; Majano PL; Fresno M; Cabañas C; López-Cabrera M
    J Pathol; 2013 Dec; 231(4):517-31. PubMed ID: 24114721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed cell death 4 and microRNA 21 inverse expression is maintained in cells and exosomes from ovarian serous carcinoma effusions.
    Cappellesso R; Tinazzi A; Giurici T; Simonato F; Guzzardo V; Ventura L; Crescenzi M; Chiarelli S; Fassina A
    Cancer Cytopathol; 2014 Sep; 122(9):685-93. PubMed ID: 24888238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. False-negative peritoneal cytology in metastatic ovarian carcinoma.
    Pretorius RG; Lee KR; Papillo J; Baker S; Belinson J
    Obstet Gynecol; 1986 Nov; 68(5):619-23. PubMed ID: 3763072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors.
    Gubbels JA; Belisle J; Onda M; Rancourt C; Migneault M; Ho M; Bera TK; Connor J; Sathyanarayana BK; Lee B; Pastan I; Patankar MS
    Mol Cancer; 2006 Oct; 5(1):50. PubMed ID: 17067392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normalization of the ovarian cancer microenvironment by SPARC.
    Said N; Socha MJ; Olearczyk JJ; Elmarakby AA; Imig JD; Motamed K
    Mol Cancer Res; 2007 Oct; 5(10):1015-30. PubMed ID: 17951402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis.
    Slack-Davis JK; Atkins KA; Harrer C; Hershey ED; Conaway M
    Cancer Res; 2009 Feb; 69(4):1469-76. PubMed ID: 19208843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic cancer-derived exosomes promote tumor metastasis and liver pre-metastatic niche formation.
    Yu Z; Zhao S; Ren L; Wang L; Chen Z; Hoffman RM; Zhou J
    Oncotarget; 2017 Sep; 8(38):63461-63483. PubMed ID: 28969005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressing effects of dietary supplementation of soybean trypsin inhibitor on spontaneous, experimental and peritoneal disseminated metastasis in mouse model.
    Kobayashi H; Fukuda Y; Yoshida R; Kanada Y; Nishiyama S; Suzuki M; Kanayama N; Terao T
    Int J Cancer; 2004 Nov; 112(3):519-24. PubMed ID: 15382080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human ovarian epithelial adenocarcinoma with peritoneal metastasis and ascites established in murine models].
    Li WJ; Qian HN
    Zhonghua Fu Chan Ke Za Zhi; 1993 Jan; 28(1):38-40, 61. PubMed ID: 8504709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer.
    Yamamura S; Matsumura N; Mandai M; Huang Z; Oura T; Baba T; Hamanishi J; Yamaguchi K; Kang HS; Okamoto T; Abiko K; Mori S; Murphy SK; Konishi I
    Int J Cancer; 2012 Jan; 130(1):20-8. PubMed ID: 21503873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LC-MS/MS analysis of ovarian cancer metastasis-related proteins using a nude mouse model: 14-3-3 zeta as a candidate biomarker.
    He Y; Wu X; Liu X; Yan G; Xu C
    J Proteome Res; 2010 Dec; 9(12):6180-90. PubMed ID: 21028892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.